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RIP3: a molecular switch for necrosis
and inflammation
Kenta Moriwaki and Francis Ka-Ming Chan1
Department of Pathology, Immunology and Microbiology Program, University of Massachusetts Medical School, Worcester,
Massachusetts 01605, USA
The receptor-interacting protein kinase 3 (RIP3/RIPK3)
has emerged as a critical regulator of programmed necrosis/
necroptosis, an inflammatory form of cell death with
important functions in pathogen-induced and sterile
inflammation. RIP3 activation is tightly regulated by
phosphorylation, ubiquitination, and caspase-mediated
cleavage. These post-translational modifications coordi-
nately regulate the assembly of a macromolecular signal-
ing complex termed the necrosome. Recently, several
reports indicate that RIP3 can promote inflammation
independent of its pronecrotic activity. Here, we review
our current understanding of the mechanisms that drive
RIP3-dependent necrosis and its role in different inflam-
matory diseases.
Cell number is tightly regulated by cell division and
cell death to maintain tissue homeostasis in multicel-
lular organisms. A classic example is found in Caenor-
habditis elegans, in which unneeded or unwanted cells
are eliminated by cell death at specific times during
development (Sulston and Horvitz 1977). Because of its
specific timing and pattern, the term programmed cell
death was coined to describe cell death during normal
animal development (Lockshin and Williams 1964). The
morphology of the dying cells under electron microscopy
revealed cell shrinkage, chromatin condensation, and
cellular fragmentation. The name apoptosis was used
to describe this type of cell death because programmed
death resembles that of leaves falling off a tree (Kerr et al.
1972). Apoptosis during development is an inherently
programmed phenomenon, as the discovery of ced-3, ced-4,
and ced-9 in C. elegans demonstrates a genetic network
that controls the process (Ellis and Horvitz 1986). Al-
though programmed cell death and apoptosis are often
used as synonyms, it is noteworthy that apoptosis can be
induced by a myriad of external cues that do not regulate
developmental processes.
The term necrosis describes cell death with swelling
of organelles and plasma membrane rupture. Necrosis
was once considered accidental cell death caused by
overwhelming physical or chemical trauma. However, we
now know that specific genes can induce necrosis in a
regulated manner. The terms programmed necrosis, nec-
roptosis, or regulated necrosis have been used to distin-
guish these types of cell death from accidental necrosis.
Programmed necrosis is induced by many stimuli, such as
intracellular ATP depletion, disturbance of Ca2+ homeo-
stasis, mitochondrial depolarization, poly-(ADP-ribose)
polymerase (PARP) activation, proteolysis by nonapo-
ptotic proteases, increased reactive oxygen species (ROS),
and cell surface receptor activation. There is evidence that
these signals use distinct and yet overlapping mechanisms
to induce necrosis (Vanlangenakker et al. 2012).
Death cytokines in the tumor necrosis factor (TNF)
family are classic inducers of programmed necrosis.
Receptor-interacting protein kinase 1 (RIP1) and RIP3,
the two critical kinases that mediate TNF-dependent
necrosis, have been in the spotlight lately because of
their unique signaling mechanisms and pathological
functions (Chan 2012). Carswell et al. (1975) originally
discovered TNF as the factor that induces rapid hemor-
rhagic necrosis in cancer cells. However, most of the early
work had focused on the molecular mechanisms and
pathophysiological roles of TNF in inflammation and
apoptosis. In 1988, TNF was shown to induce necrosis in
a cell line derived from the L929 cells that Carswell et al.
(1975) used to examine TNF activity (Laster et al. 1988).
It was not until 2000 when Holler et al. (2000) demon-
strated that RIP1 is a key regulatorymolecule of necrosis
induced by the death receptor ligands TNF, Fas ligand,
and TNF-related apoptosis-inducing ligand (TRAIL). Un-
fortunately, progress in the fieldwas stalled in part because
RIP1/ mice suffer from perinatal lethality (Kelliher
et al. 1998). Research on necrosis got a significant boost
when necrostatins, a class of chemical inhibitors of
RIP1, became available (Degterev et al. 2005, 2008). In
2009, another RIP family member, RIP3, was identified
as a crucial regulator of death receptor-induced necrosis
(Cho et al. 2009; He et al. 2009; Zhang et al. 2009). The
fact that RIP3/ mice have no remarkable develop-
mental defects dramatically facilitated the study of necro-
sis in pathophysiology.
[Keywords: RIP1; MLKL; PGAM5; caspase 8; FADD; inflammation]
1Corresponding author
E-mail francis.chan@umassmed.edu
Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.223321.113.
1640 GENES & DEVELOPMENT 27:1640–1649  2013 by Cold Spring Harbor Laboratory Press ISSN 0890-9369/13; www.genesdev.org
 Cold Spring Harbor Laboratory Press on February 1, 2015 - Published by genesdev.cshlp.orgDownloaded from 
RIP3—the key player in the necrosis signaling pathway
Structural organization of RIP3
RIP3 was first identified by two different groups through
yeast two-hybrid screening and database searches as a
RIP1-binding protein with homology with RIP1 and RIP2
(Sun et al. 1999; Yu et al. 1999). The human rip3 gene is
located on chromosome 14 (Kasof et al. 2000), and its
mRNA encodes a polypeptide of 518 amino acids (Fig. 1).
RIP3 has an active kinase domain in its N terminus that
is conserved in other RIP kinases and is essential for
necrosis. Unlike the N termini, each RIP family member
encodes a unique C terminus: death domain in RIP1,
caspase recruitment domain (CARD) in RIP2, and an
ankyrin repeat in RIP4. The unique C termini dictate their
recruitment to different signaling scaffolds. For RIP3, a
rather degenerate C-terminal motif termed the RIP homo-
typic interaction motif (RHIM), which is also present in
the intermediate domain of RIP1, mediates its interaction
with RIP1 and necrosis (Fig. 1; Sun et al. 2002).
The role of RIP3 in apoptosis, NF-kB activation,
and necrosis
Early experiments using overexpression systems implicate
RIP3 in apoptosis and NF-kB signaling (Sun et al. 1999; Yu
et al. 1999; Meylan et al. 2004). However, RIP3/ thymo-
cytes responded normally to different apoptosis stimuli,
and RIP3/ fibroblasts or macrophages were normal
for TNF- and toll-like receptor (TLR) ligand-induced
NF-kB activation (Newton et al. 2004). While we cannot
rule out that RIP3 might regulate apoptosis or NF-kB
signaling in unique circumstances, these results indicate
that RIP3 does not have a central role in apoptosis or NF-kB
activation.
The first hint that RIP3 might regulate necrosis also
came from overexpression studies. Feng et al. (2007)
showed that human RIP3 was cleaved at Asp328 (D328).
When a noncleavable mutant of human RIP3 was ex-
pressed in cells, it led to caspase-independent cell death
(Feng et al. 2007). Similar cleavage ofmouse RIP3 has since
been reported (Zhang et al. 2009). However, Feng et al.
(2007) concluded that the cell death caused by the mutant
RIP3 was apoptosis. Subsequently, three independent
studies unequivocally demonstrated that RIP3-driven cell
death was necrotic rather than apoptotic (Cho et al. 2009;
He et al. 2009; Zhang et al. 2009). Since then, RIP3 has
been shown to be a critical switch that drives necrosis
induced by TNF-like death receptors TLR3 and TLR4 and
the T-cell receptor (Cho et al. 2009; Ch’en et al. 2011; He
et al. 2011). The most extensively characterized pathway
leading to RIP3 activation during necrosis is initiated by
TNF. The ligation of TNF to TNF receptor 1 (TNF-R1)
causes the formation of the membrane-associated TNF-R1
signaling complex termed complex I, which consists of
multiple protein adaptors, including TNFR-associated
death domain (TRADD), RIP1, cellular inhibitor of apo-
ptosis 1 (cIAP1), cIAP2, TNFR-associated factor 2 (TRAF2),
Figure 1. Domain organization of human RIP family proteins. The phospho-acceptor sites are highlighted with the letter P. The
crucial lysine residues in the ATP-binding pocket are shown (K45 in RIP1, K47 in RIP2, K50 in RIP3, and K51 in RIP4). M92 is the
‘‘gatekeeper residue’’ in RIP1 that is important for kinase activity (Lu et al. 2011).
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and the linear ubiquitin chain assembly complex (LUBAC)
(Fig. 2). RIP1 ubiquitination mediated by cIAPs and
LUBAC in complex I is a critical event to trigger the
NF-kB pathway (Gerlach et al. 2011) and block apoptosis
and necrosis (O’Donnell et al. 2012). Deubiquitination of
RIP1 by CYLD promotes apoptosis and necrosis through
the formation of the cytoplasmic death-inducing signal-
ing complex termed complex II (Hitomi et al. 2008, Wang
et al. 2008). In addition to RIP1, complex II also contains
caspase-8, Fas-associated protein with death domain
(FADD), and cellular FLICE-like inhibitory protein (cFLIP).
FADD and caspase-8 promote apoptosis by activating
downstream caspases and inhibit necrosis through cleav-
age of RIP1, RIP3, and CYLD (Lin et al. 1999; Chan et al.
2003; Feng et al. 2007; O’Donnell et al. 2011). When
caspase-8 activity is blocked by genetic ablation, chemical
inhibitors, or viral caspase inhibitors, RIP1 and RIP3 turn
complex II into a necrosis-inducing signaling complex
that is often referred to as the necrosome (Declercq et al.
2009).
Phosphorylation regulates necrosome assembly
and activity
Necrostatins, which inhibit RIP1 kinase activity by bind-
ing to the kinase domain and locking RIP1 in its inactive
Figure 2. Overview of RIP3-dependent necrosis and inflammation. Ligation of TNF to TNF-R1 leads to the formation of complex I,
where RIP1 is ubiquitinated by cIAP1/2 and LUBAC. Deubiquitination of RIP1 by CYLD converts the signal from cell survival to cell
death by facilitating the formation of complex II. Fas ligand and TRAIL also induce complex II formation. Active caspase-8 in this
complex induces apoptosis and inhibits necrosis by cleaving RIP1, RIP3, and CYLD. When caspase-8 is inhibited, the amyloid
RIP1/RIP3 necrosome is formed. Necrosome formation causes necrosis through the mitochondrial pathway mediated by MLKL,
recruitment of PGAM5L and PGAM5s, and activation of Drp1. PGAM5 and Drp1 also mediate necrosis induced by ROS and calcium
ionophore. TLR3 and TLR4 activation by pathogen-associated molecular patterns (PAMPs) such as dsRNA and LPS lead to RIP3
binding to TRIF and necrosis. For the T-cell receptor (TCR), the mechanism that activates RIP3-dependent necrosis is still unknown.
Membrane rupture results in the release of DAMPs to an extracellular space where innate immune cells such as macrophages and DCs
are located. These innate immune cells recognize DAMPs during infection or tissue damage to elicit an inflammatory cytokine
response. Besides necrosis, RIP3 can also drive IL-1b production in caspase-8-deficient DCs or when IAP proteins are eliminated by
SMs. (APC) Antigen-presenting cells; (MHC) major histocompatibility complex.
Moriwaki and Chan
1642 GENES & DEVELOPMENT
 Cold Spring Harbor Laboratory Press on February 1, 2015 - Published by genesdev.cshlp.orgDownloaded from 
conformation (Degterev et al. 2008; Xie et al. 2013),
blocked necrosome assembly (Cho et al. 2009). Hence,
the kinase activity of RIP1 is indispensable for necrosome
assembly. Mass spectroscopy revealed that RIP1 is auto-
phosphorylated at multiple serine residues in the kinase
domain (Degterev et al. 2008), suggesting that phosphor-
ylation might regulate its kinase activity. Surprisingly,
alanine substitution of individual serine residue had mini-
mal effects onRIP1 kinase activity (TMcQuade and FChan,
unpubl.). Therefore, one can speculate that the cumulative
effect of the negative charge on multiple phospho-serine
residues might be important for activity. In addition to
autophosphorylation, RIP1 kinase activity might also
be regulated by RIP3. For instance, RIP3 could directly
phosphorylate RIP1 in vitro, and necrosis-induced RIP1
phosphorylation was abrogated in RIP3/ cells (Cho et al.
2009). In contrast, a kinase-inactive RIP3 mutant that
could not mediate necrosis was nonetheless able to com-
plex with RIP1 (He et al. 2009; Wang et al. 2012).
Like RIP1, RIP3 is highly phosphorylated upon necrosis
induction. Because phosphorylation of RIP3 was inhibited
by Nec-1, RIP1 is likely the upstream kinase that initiates
necrosis signaling (Cho et al. 2009). One phosphorylation
site on RIP3, Ser227 (Thr231/Ser232 for mouse RIP3), is
particularly important for recruitment and activation of
mixed-lineage kinase domain-like (MLKL), a crucial down-
stream substrate of RIP3 in the necrosis pathway (Sun et al.
2012; Chen et al. 2013). Although there are other phos-
phorylated serine/threonine residues on RIP3 (Chen et al.
2013), their roles in RIP3 activation are less defined. Col-
lectively, these results are most consistent with a model
in which RIP3 binding provides a scaffold on which RIP1
becomes activated. Once activated by autophosphoryla-
tion, RIP1 can proceed to phosphorylate downstream
targets, including RIP3.
Necrosome formation is also tightly regulated by
ubiquitination (see above) and acetylation. A recent study
found that RIP1 was acetylated at Lys530 (Narayan et al.
2012). Deacetylation by sirtuin2 (SIRT2), which constitu-
tively binds to RIP3, facilitated TNF-induced necrosis.
These results suggest that one of the early events that
stabilize the RIP1–RIP3 necrosome could be SIRT2-
mediated deacetylation of RIP1. More work is required to
confirm the role of SIRT2 and RIP1 acetylation in physi-
ological necrosis.
The amyloidal nature of the necrosome
The interaction between RIP1 and RIP3 is mediated by
the RHIM, a hydrophobic patch of b sheet (IQIGXXN for
RIP1 [amino acids 539–542] and VQVGXXN for RIP3
[amino acids 458–461]) flanked by unstructured coiled-like
residues. Detailed biochemical and biophysical study
showed that the RHIMs of RIP1 and RIP3 mediate forma-
tion of a filamentous structure with classical characteris-
tics of b-amyloids (Li et al. 2012). Mutations of the core
RHIM residues of RIP1 (IQIG) or RIP3 (VQVG) disrupted
the assembly of this b-amyloid structure, RIP kinase ac-
tivation, and necrotic cell death. These results suggest that
the RIP kinase activities and necrosome assembly might
function in a feed-forward manner to amplify the prone-
crotic signal (Fig. 2).
The amyloid scaffold of the necrosome raises several
important questions. For example, since RIP1 and RIP3 can
bind to pronecrotic (e.g., MLKL) as well as anti-necrotic
factors (FADD and caspase-8), does amyloid assembly
dictate whether apoptosis or necrosis will ensue upon
TNF stimulation? Do RIP1 and RIP3 become resistant to
caspase-8 cleavage and inhibition when they assemble
into the b-amyloid complex? Does the structural simi-
larity of the necrosome to neurotoxic amyloidal fibrils
suggest a role for necrosis in neurodegeneration? These
are some of the interesting and important questions to
be addressed in the future.
RHIM in other innate immune signaling adaptors
The RHIM is also found in other adaptors with important
functions in innate immunity and cell death. These
include the TIR domain-containing adaptor-inducing
interferon-b (IFNb) (TRIF) (Meylan et al. 2004; Kaiser
and Offermann 2005), the DNA-dependent activator of
IFN regulatory transcription factors (DAI/ZBP1/DLM-1)
(Kaiser et al. 2008; Rebsamen et al. 2009), and the viral
inhibitor of RIP activation (vIRA/M45) from murine cyto-
megalovirus (MCMV) (Upton et al. 2008). In overexpres-
sion studies, RIP1 and RIP3 could bind to many of these
RHIM-containing proteins. Interestingly, some of these
‘‘noncanonical’’ RHIM–RHIM interactions also appear to
drive necrosis. For example, bacterial lipopolysaccharide
(LPS), a ligand for TLR4, induced RIP3 and TRIF binding
and necrosis in macrophages (He et al. 2011). In contrast,
during MCMV infection, vIRA/M45 inhibits RIP3 binding
to DAI to prevent premature necrosis of the infected cells,
a process that is salient for productive viral replication
(Upton et al. 2010, 2012). Thus, not all RHIM–RHIM in-
teractions result in cell death. To complicate matters
further, RHIM-mediated interaction between RIP1 and
TRIF or DAI also drives downstream NF-kB activation
(Kaiser et al. 2008; Rebsamen et al. 2009), an event that is
usually associated with cell survival. It will be interesting
to determine whether these non-death-inducing RHIM-
dependent interactions also use b-amyloid assembly as a
signaling platform.
Downstream execution of RIP3-dependent necrosis
As discussed above, MLKL is a recently identified RIP3
substrate. MLKL binds RIP3 through its C-terminal
kinase-like domain, which is phosphorylated by RIP3 at
Thr357 and Ser358. Mutations of MLKL at these residues
blocked necrosis but not binding to RIP3 (Sun et al. 2012).
Although the name implies that itmay not be an authentic
kinase, MLKL expressed in HEK293T cells could weakly
phosphorylate myelin basic protein (MBP) in vitro (Zhao
et al. 2012). Moreover, expression of an MLKLmutant in
which the lysine residues in the ATP-binding pocket
were substituted with alanines failed to restore TNF-
induced necrosis in fibroblasts lacking MLKL expression
(Zhao et al. 2012). Whether this weak kinase activity of
RIP3 in necrosis and inflammation
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MLKL is important for necrosome activity remains to be
tested.
A fundamental feature of necrosis is the loss of cellular
membrane potentials, which may be caused by depletion
of intracellular ATP, damaged membrane lipids, and/or
loss of function of ATP-dependent ion pumps. Disrupted
membrane potential can lead to organelle swelling, mito-
chondrial damage, and plasma membrane rupture that are
often associated with necrosis. Howmight RIP3 regulate
these cellular changes? One recent study shows that
phosphoglycerate mutase 5 (PGAM5), a resident mito-
chondrial protein, may play a role in the execution of
cellular necrosis (Wang et al. 2012). PGAM5 exists in two
isoforms: PGAM5 long and short (PGAM5L and PGAM5s).
When PGAM5s is recruited to the RIP1/RIP3 necrosome
by MLKL and becomes phosphorylated, it dephosphory-
lates and activates the mitochondrial fission protein Drp1.
Drp1 activation causes mitochondrial fission and ROS
production. Hence, PGAM5 may promote ROS produc-
tion that causes the cellular damage observed in necro-
sis. Although this is a fascinating model, ROS scaven-
gers could not inhibit all forms of necrosis (Temkin et al.
2006). Does that mean that PGAM5 and ROS are only
required for necrosis in certain cell types? Further work
is needed to clarify the role of PGAM5 in different cell
types and identify whether additional effectors beyond
Drp1 are involved.
RIP3 function in embryonic development
Unlike apoptosis, necrosis is not normally detected during
embryogenesis. However, mice deficient in the essential
apoptosis regulators Bax and Bak developed normally (Wei
et al. 2001), indicating that nonapoptotic cell death can
contribute to embryonic development when apoptosis is
impaired. In contrast, caspase-8/ and FADD/mice die
on embryonic day 10.5 (E10.5) due to a defect in hemato-
poietic precursors in endothelium and failure in yolk sac
vascularization (Varfolomeev et al. 1998; Yeh et al. 1998;
Kang et al. 2004). The lethality might be due to excessive
RIP kinase-dependent necrosis. Indeed, the lethality of
caspase-8/ and FADD/mice was rescued by germline
inactivation of RIP1 or RIP3 (Kaiser et al. 2011; Oberst
et al. 2011; Zhang et al. 2011). Mice deficient in the anti-
apoptotic protein cFLIP also suffer from similar embryonic
lethality (Yeh et al. 2000). Surprisingly, RIP3 deletion did
not rescue this phenotype because the caspase-8 homo-
dimer could still form to promote apoptosis (Dillon et al.
2012). This surprising finding is consistent with the fact
that the caspase-8/cFLIP heterodimer has restricted cleav-
age activity compared with the caspase-8 homodimer,
such that it cannot induce apoptosis but is still sufficient
to cleave and inhibit RIP1 and/or RIP3 (Oberst et al. 2011).
Consistent with this proposition, RIP3/FADD double
deficiency rescued the lethality of cFLIP/ mice (Dillon
et al. 2012).
Besides rescuing the lethality of FADD/ and caspase-
8/ mice, RIP3 deficiency also partially inhibited the
lethality of mice lacking multiple cellular IAPs. The IAPs
are RING-containing E3 ligases that promote cell survival
through canonical NF-kB activation (cIAP1 and cIAP2)
or by direct binding to caspases (XIAP) (Silke and Meier
2013). Germline deletion of individual IAP had no overt
effects on development (Harlin et al. 2001; Conze et al.
2005; Conte et al. 2006). In contrast, cIAP1/cIAP2/ or
cIAP1/XIAP/ mice died around E10.5 due to hemor-
rhages and cardiovascular defect (Moulin et al. 2012),
suggesting certain functional redundancy among the IAPs.
Interestingly, TNFR-1 deficiency allowed cIAP1/cIAP2/
mice to survive until birth (Moulin et al. 2012). However,
inactivation of RIP3 only prolonged survival for a few days
during embryogenesis. Surprisingly, cIAP1/XIAP/mice
that were hemizygous for RIP1 were born alive, while
cIAP1/XIAP/RIP1/ mice did not survive past E14.5
(Moulin et al. 2012). The molecular mechanisms that
contribute to these confounding observations are unclear
at present. Nonetheless, they do indicate that gene dosage
can greatly impact the outcome of RIP kinase signaling
during embryonic development.
RIP3 in viral and bacterial infections
Apoptosis is a major host defense mechanism against viral
infection. To circumvent apoptosis of infected cells and
establish successful infection, many viruses encode cas-
pase inhibitors. When the apoptosis pathway is blocked,
RIP3-dependent necrosis can function as a backup host
defense mechanism to limit viral replication. Consistent
with this notion, RIP3/mice failed to eliminate vaccinia
virus and succumbed to the infection (Cho et al. 2009). In
contrast, MCMV has evolved and developed inhibitors
to prevent both apoptosis and necrosis (see above). Failure
to block necrosis compromised the fitness of the virus,
leading to abortive infection in the host (Upton et al. 2010,
2012).
Severe bacterial infection can lead to sepsis that is
characterized by overwhelming cytokine production and
life-threatening systemic organ failure. TNF is a prime
mediator of inflammation in septic shock, implying that
RIP3 might also participate in bacterial-induced sepsis
(Bhatia et al. 2009). Indeed, RIP3/ mice were protected
from TNF or cecal ligation and puncture (CLP)-induced
systemic inflammation, two experimental models for
clinical sepsis (Duprez et al. 2011; Linkermann et al.
2012). In addition, RIP3 also plays a crucial role in the
pathogenesis of Salmonella enterica serovar Typhimu-
rium. S. Typhimurium is a facultative intracellular patho-
gen that replicates in intestinal epithelia to cause gastro-
enteritis. Early reports show that S. Typhimurium causes
caspase-1-dependent pyroptosis in macrophages (Fink
et al. 2008; Miao et al. 2010). Similar to necrosis, pyropto-
sis is marked by plasma membrane rupture and release
of danger-associated molecular patterns (DAMPs), which
induce inflammation by activating cognate pattern recog-
nition receptors. However, necrosis and pyroptosis are
regulated by distinct molecular machineries. Recently,
S. Typhimurium was shown to kill macrophages in a
type I IFN- and RIP3-dependent manner (Robinson et al.
2012). IFNa/b receptor-deficient or RIP3/ mice exhib-
ited reduced macrophage necrosis and better control of
Moriwaki and Chan
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S. Typhimurium. Although the investigators conclude
that this is directly due to RIP3-dependent necrosis, one
should also consider the possibility that the dampened
cytokine response due to reduced necrosis and DAMP
release could have also contributed to the protection in
RIP3/ mice.
RIP3 in lymphocyte homeostasis
Lymphocyte homeostasis is finely balanced between cell
proliferation and cell death. This concept is best illus-
trated by mutations in the death receptor Fas/CD95/
APO-1, which lead to autoimmune lymphoproliferative
diseases in humans andmice that resemble lupus. Because
Fas is a major inducer of caspase-dependent apoptosis,
apoptosis was thought to be the dominant mechanism by
which autoreactive lymphocytes are eliminated. Paradox-
ically, T cells that lack FADD or caspase-8 or those that
express a dominant-negative version of FADD developed
immunodeficiency instead of lymphoproliferation (Newton
et al. 1998; Walsh et al. 1998; Zhang et al. 1998, 2005;
Salmena et al. 2003). In response to antigen receptor
stimulation, these T cells failed to clonally expand due
to premature cell death by necrosis. Normal proliferation
was restored by genetic ablation of RIP1 or RIP3 (Osborn
et al. 2010; Ch’en et al. 2011; Lu et al. 2011; Zhang et al.
2011). Moreover, caspase-8/RIP3/mice developed lpr/
gld-like lymphoproliferation and lupus-like disease (Oberst
et al. 2011). Therefore, while caspase-dependent apoptosis
is the dominant cell death mechanism for lymphocytes,
immune homeostasis also requires the coordinate effort
of RIP kinase-dependent necrosis.
RIP3 in sterile inflammation
Hepatocytes are highly susceptible to the cytotoxic ef-
fects of TNF. Normally, hepatocytes are protected from
the death-inducing effect of TNF because of NF-kB-
induced expression of survival factors. As such, hepato-
cytes that lacked NF-kB essential modulator (NEMO)
underwent spontaneous apoptosis, leading to inflamma-
tion, steatosis, liver fibrosis, and hepatocellular carcinoma
(Luedde et al. 2007). Caspase-8DHepa mice also developed
spontaneous liver inflammation and enhanced nonapo-
ptotic liver injury (Liedtke et al. 2011; Hatting et al. 2013).
Combined hepatocyte-specific caspase-8 and NEMO de-
letion further exacerbated liver necrosis and cholestasis
(Liedtke et al. 2011). Since RIP1/RIP3/FADD complexes
were detected in these cases, it is tempting to speculate
that RIP3-dependent necrosis was responsible for the liver
pathologies. In support of this hypothesis, RIP3/ mice
were protected from ethanol-induced expression of proin-
flammatory cytokines, hepatocyte injury, and steatosis
(Roychowdhury et al. 2013).
Deficiency of caspase-8 or FADD in intestinal or skin
epithelium spontaneously caused massive inflamma-
tion, which was rescued by additional deletion of RIP3
(Kovalenko et al. 2009; Bonnet et al. 2011; Gunther et al.
2011; Welz et al. 2011). Interestingly, TNF-R1 deficiency
did not fully rescue excessive necrosis and inflammation
in the intestine and skin, indicating that physiological
necrosis can often be induced by ligands other than TNF
(Bonnet et al. 2011; Welz et al. 2011).
Although necrosis is optimally induced when caspases
are inhibited, it can also occur in the presence of intact
FADD or caspase-8 function. For example, cerulein-
induced acute necrotizing pancreatitis was reduced in
RIP3/ mice (He et al. 2009; Zhang et al. 2009). RIP3
deficiency inhibited photoreceptor cell death in a retinal
detachment model and cone cell death in Rd10 mice
that develop retinitis pigmentosa (Trichonas et al. 2010;
Murakami et al. 2012). Necrotic macrophages have been
observed in atherosclerosis lesions from human patients
and animal models of atherosclerosis (Tabas 2010). In-
terestingly, RIP3 deficiency alleviated macrophage ne-
crosis in advanced atherosclerosis lesions in atheroscle-
rosis-prone LDL-R/ or ApoE/ mice (Lin et al. 2013),
indicating that RIP3-dependent necrosis is a key driver
for inflammation in atherosclerosis.
Necrosis-independent function of RIP3 in inflammation
The release of cellular DAMPs is believed to be the main
driver of inflammation in physiological necrosis. Recently,
several reports show that RIP3 can also facilitate inflam-
mation independent of necrosis. Production of the in-
flammatory cytokine IL-1b requires two distinct signals:
a first signal that induces de novo pro-IL-1b gene tran-
scription through NF-kB and a second inflammasome-
dependent signal that cleaves pro-IL-1b to produce the
mature cytokine. The inflammasome is a macromolecular
complex composed of caspase-1, the adaptor ASC1, and an
upstream sensor such as NLRP3. Thus, stimulation of
TLR4 with LPS alone, which provides the first signal, is
not sufficient to induce mature IL-1b expression in bone
marrow-derived macrophages. Surprisingly, SMAC mi-
metic (SM), which targets the IAPs for proteasomal
degradation, promotes NLRP3 inflammasome activation
and IL-1b maturation in LPS-primed macrophages and
dendritic cells (DCs) (Vince et al. 2012). Similar results
were obtained with cIAP1/cIAP2/XIAP/ macro-
phages. Strikingly, inflammasome activation in these
conditions requires RIP3 but not necrosis.
In addition to SM, caspase-8 deficiency also appears to
turn on RIP3-dependent inflammasome activation in DCs.
Mice with DC-specific deletion of caspase-8 developed an
aggressive systemic inflammatory disease and were highly
susceptible to the lethal effect of LPS (Kang et al. 2013).
LPS stimulation of caspase-8/ DCs led to enhanced
activation of the NLRP3/ASC/caspase-1 inflammasome
and IL-1b expression. Inhibition of RIP1 by necrostatins or
RIP3 deficiency restored normal inflammasome activity.
Surprisingly, using RNAi, the investigators showed that
the downstream necrosis regulators MLKL and PGAM5
were also required for heightened inflammasome acti-
vation in caspase-8/ DCs. Although the investigators
concluded that enhanced in vitro IL-1b secretion in
caspase-8/ DCs was independent of the pronecrotic role
of RIP3, low level of necrosis could still occur to promote
inflammation in vivo because caspase-8/ cells are highly
RIP3 in necrosis and inflammation
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sensitive to necrosis. Spontaneous inflammation was also
observed in mice lacking FADD in DCs. However, in
contrast to the results from the DC-specific caspase-8/
mice, the phenotypes were caused by excessive exposure
to commensal microbiota and DC necrosis (Young et al.
2013). More research into the role of RIP3 in systemic
inflammation and DC biology is required to reconcile
the discrepant interpretations from these studies.
Potential role of RIP3 in cancer
Although the concept that apoptosis can serve as a natural
barrier to cancer development has been well established,
the role of necrosis in cancers remains unknown. It is
noteworthy that necrosis is a characteristic feature of
many advanced solid tumors (Hanahan and Weinberg
2011). However, there is no clear evidence to indicate
whether necrosis is beneficial or harmful in cancers. One
of the challenges in clinical cancer therapy is the re-
sistance of cancers to apoptosis. Since many anti-cancer
drugs are inducers of apoptosis, inducing RIP3-dependent
necrosis is an attractive strategy to circumvent apoptosis
resistance of cancer cells. In addition to DNA alkylating
agents, which induce necrosis in the PARP-dependent
manner (Zong et al. 2004; Fu et al. 2013; Sosna et al. 2013),
some drugs were reported to induce RIP3-dependent
necrosis in certain conditions (Tenev et al. 2011; Bray
et al. 2012; Basit et al. 2013). Because necrosis also
facilitates inflammation, its effect on inflammation in
the tumor microenvironment has to be carefully con-
sidered (Mantovani et al. 2008). Further work is required
to answer these important questions and understand how
we can harness the power of RIP3-dependent necrosis in
cancer therapy.
Closing thoughts
Much has been learned about the role of RIP3 in different
disease pathologies in recent years. With this newfound
understanding, it is perhaps tempting to ponder how we
might integrate this knowledge into clinical applications.
However, several hurdles must first be overcome. For
instance, we must learn whether RIP3 actually induces
necrosis and inflammation in human diseases when
FADD and caspase-8 functions are intact. Technologies
that allow us to monitor the activation status of RIP3
and quantify RIP3-dependent necrosis will be vital in
this endeavor. At present, electron microscopy remains
the most reliable way to distinguish necrosis in diseased
tissues. More quantitative methods to detect necrosis
and differentiate it from apoptosis need to be developed.
In addition, we need to create ways to differentiate active
RIP3 during necrosis versus inflammasome activation.
Finally, onemust consider whether RIP3 is indeed a good
target for therapeutic intervention. Given the diverse
biological processes that RIP1 regulates, it is safe to as-
sume that RIP3 is a better therapeutic target than RIP1.
However, as in the case ofmany other cell death regulators,
RIP3 can have other ‘‘day jobs,’’ such as that in inflamma-
some activation. Therefore, the success of RIP3-targeted
therapies will depend on whether we can differentiate RIP3
functions in various biological responses.
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